- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01207232
The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates
September 21, 2010 updated by: University of Pennsylvania
The investigators conducted a 3-arm randomized controlled trial to test whether a low-cost planning intervention could increase influence vaccination rates.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Seasonal influenza causes 20,000 hospitalizations and 36,000 deaths in the U.S. each year.
Past psychology research has demonstrated that prompting people to form an implementation plan of the form, "When situation x arises, I will implement response y," increases attainment of desired goals because the desired behavior is linked to a concrete future moment.
This type of planning prompt is a "nudge" in the direction of desired behavior that can be implemented at minimal expense and does not restrict individual autonomy.
We conducted a 3-arm randomized controlled trial to test whether a low-cost planning intervention could increase influence vaccination rates.
We show that planning prompts can be successfully applied to improve health behaviors.
Study Type
Interventional
Enrollment (Actual)
3272
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Vaccine indications according to fall 2009 CDC criteria (age >= 50 or chronic disease
- Employee at partner corporation that implemented the study
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Time Plan Condition
A basic reminder mailing prompted each subject to write down a planned date and time for getting their flu shot.
|
A prompt to write down a planned date (or date and time) for getting a flu shot
|
|
Experimental: Date Plan Condition
A basic reminder mailing prompted each subject to write down a planned date for getting their flu shot.
|
A prompt to write down a planned date (or date and time) for getting a flu shot
|
|
Active Comparator: Control Condition
A basic reminder mailing prompted each subject to receive a flu shot.
|
A basic reminder mailing prompted each subject to get their flu shot.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Receipt of 2009 Seasonal Influenza Vaccination
Time Frame: up to 30 weeks
|
up to 30 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Katherine L Milkman, Ph.D., University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (Actual)
November 1, 2009
Study Completion (Actual)
April 1, 2010
Study Registration Dates
First Submitted
September 20, 2010
First Submitted That Met QC Criteria
September 21, 2010
First Posted (Estimate)
September 22, 2010
Study Record Updates
Last Update Posted (Estimate)
September 22, 2010
Last Update Submitted That Met QC Criteria
September 21, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 810589-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seasonal Influenza
-
National Institute of Allergy and Infectious Diseases...RecruitingSeasonal Influenza | Influenza PreventionUnited States
-
Virginia Commonwealth UniversityCompletedSeasonal Influenza | H1N1 InfluenzaUnited States
-
Novartis VaccinesCompletedInfluenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza VirusBelgium
-
Sinovac Biotech Co., LtdCompletedA Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 MonthsSeasonal InfluenzaChina
-
Sinovac Biotech Co., LtdCompletedSeasonal InfluenzaChina
-
ModernaTX, Inc.CompletedSeasonal InfluenzaUnited States
-
ModernaTX, Inc.Completed
-
NovartisNovartis VaccinesCompletedSeasonal InfluenzaGermany
-
Novartis VaccinesCompleted
-
Novartis VaccinesCompleted
Clinical Trials on Planning Prompt
-
University of PennsylvaniaCompletedIn Need of a Pap Smear (Cervical Cancer Screening) | In Need of a Blood Pressure Check (Hypertension Screening) | In Need of a Cholesterol Test (Lipid Disorder Screening) | In Need of a Fasting Plasma Glucose Test (Diabetes)United States
-
University of PennsylvaniaYale University; Stanford University; Harvard UniversityCompleted
-
University of California, Los AngelesUCLA Health Department of MedicineCompletedDiabetes | Cancer | Health MaintenanceUnited States
-
Ottawa Heart Institute Research CorporationActive, not recruitingMitral Regurgitation (MR) | Moderate or Severe Aortic Stenosis (AS) (Mean Pressure Gradient ≥ 20 mm Hg or Aortic Valve Area ≤ 1.5 cm2)Canada
-
The Prompt InstituteCompletedRandomized Controlled Trial for Speech Disorders in ChildrenCanada
-
University of CincinnatiRobert Wood Johnson FoundationCompleted
-
Virtua Health, Inc.Rutgers UniversityTerminated
-
Stanford UniversityActive, not recruiting
-
St. Joseph's Healthcare HamiltonCompleted
-
University of PennsylvaniaCompletedBlood Pressure Check (Hypertension Screening) | Cholesterol Test (Lipid Disorder Screening)United States